Navigation Links
US Oncology, Inc. Announces Issuance of $775 Million of Debt Securities
Date:6/18/2009

s. Forward looking statements give our current expectations and projections relating to the financial condition, results of operations, plans, objectives, future performance and business of US Oncology, Inc. and its subsidiaries. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events.

These forward looking statements are based on our expectations and beliefs concerning future events affecting us. They are subject to uncertainties and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Although we believe that the expectations reflected in our forward looking statements are reasonable, we do not know whether our expectations will prove correct. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties, including those discussed under the heading "Risk Factors" in US Oncology Holdings, Inc. Annual Report on Form 10-K for the year ended December 31, 2008, and subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Debt Securities of US Oncology, Inc.
2. US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering
3. TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
4. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
5. SearchMedicas Second Quarterly Top Clinical Search Terms Report Reveals Top 25 Oncology, General Medicine and Psychiatry Search Terms Among Medical Professionals
6. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
7. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
8. The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners
9. Organization Announces End Prostate Cancer Tour
10. Claimsnet Announces Claims Processing Agreement With New Third Party Administrator
11. Foundation Announces "Turn Up the Heat on Alzheimers" Campaign

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...rt to draw definite conclusions, experts say, , ...In diabetic patients with blocked coronary arterie...t one year whether patients undergo bypass surgery... report. , Bypass surgery has been the standard...ery disease. However, less invasive approaches suc...
(Date:11/25/2009)...l symptoms, study finds , , WEDNESDAY, ...cts are among the potential problems faced by long...ted with cisplatin-based chemotherapy, a new study...n men treated for unilateral testicular cancer bet...rvey conducted from 1998 to 2002. , The researc...
(Date:11/25/2009)...4thStraightYear ,, WASHINGTON,Nov.25/PRNewswi...(LCA-GA)issuedthe 4thAnnualReportCardonLungCancer ...tthislethaldiseaseinthestateofGeorgia.LCA-GAisacha...izationdedicatedexclusivelytopatientsupportandadvo..., (Logo: http://www.newscom.com/cgi-bin/prnh/20081...
(Date:11/25/2009)...ill tumor cells, study finds , , WEDNESD...elivered in a fingernail-size implant eliminated m...The method uses polymer disks, 8.5 millimeters in ...gens and implanted under the skin to reprogram the...rsity scientists who developed the implant predict...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...he young and fair skinned tan lovers should give s...ce the development of skin cancer, the European Co...ve arm of the European Union said that its scienti...in cancer. European Commission spokesman Greg...
...latant and unwholesome food marketing is on the ri...obesity. It is evident that food marketing impacts...tary pattern and food habits that can last a lifet...food advertisements on dietary choice. They have p...
...olice today, had seized a large quantity of spurio...n for possession of drugs having fake labels of co...p-off, a police team raided a drug store in Leader...whose genuine versions would have been worth Rs 15...
...anofi Pasteur, the world's third-largest pharmaceu...y have reached an initial agreement to conduct joi...used on humans early next year.// According to...ths to 18 years owing to the increased susceptibil...
...he U.S. Food and Drug Administration has approved ...ment for multiple myeloma, which is a type of bloo...rug will now be able to market Revlimid for use in...earlier been treated with chemotherapy. The ...
...he central government Thursday assured the Delhi H...te of Medical Sciences (AIIMS) director P. Venugop...etition. Additional Solicitor General Gopal S...ng upon the AIIMS governing body's recommendation ...
Other Medicine News:Health News:Agreement for Joint Trials of Avian Flu Vac cine on Humans 2Health News:Venugopal will not be Sacked Before Court Verdict: Central Government 2
(Date:11/25/2009)...re/--TheFDAgrantedtraditionalapprovalforINTELENCE&...nscriptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTI...adultswhoareexperiencingvirologicfailurewithHIV-1s...)agents.Thetraditionalapprovalisbasedon48-weekdata...CEiscurrentlymarketedintheU.S.byTibotecTherapeutic...
(Date:11/25/2009)...ire/--RegadoBiosciences,aprivatelyheldcompanyleadi...controlagents,announcedthatDavidMazzo,PhD,CEOandPr...lHealthCareConferenceattheNewYorkPalaceHotelinNewY...EST)onTuesday,December1andwillincludeanoverviewoft...tprogram,theanticoagulantsystem,REG1.Thehealthcare...
(Date:11/25/2009)...re-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedical...ysissystems,announcedtodaythatClintSeverson,chairm...ualPiperJaffrayHealthCareConferenceonWednesday,Dec...heNewYorkPalaceHotelinNewYorkCity. ,, AboutAba...rtablebloodanalysissystemsforuseinanyveterinaryorh...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 1Identafi 28TM 29 3000 Picked by Dentistry Today Magazine as One of the Top 100 Products of 2009 50599 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 1Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 2Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 3Jury Convicts Los Angeles Physician Assistant for Stealing Doctors Identity and Defrauding Medicare in 247 7 Million Scheme 50595 4Growth Hormone May Build Muscle in Older Men 50591 1Growth Hormone May Build Muscle in Older Men 50591 2
...arch 11 InteKrin Therapeutics, Inc., a clinical s..., metabolism and obesity, today announced it has c...y of INT131, a novel, non-TZD selective modulator ... diabetes (T2DM). INT131-007 is a 24 week, high d...controlled study of INT131 at four doses in poorly...
...h 10 BioSpecifics Technologies Corp. (Nasdaq: B...t in class collagenase-based products, today annou...l present a corporate overview at the upcoming Cow...on Tuesday, March 17, 2009, at 9:30am ET at the Bo...ebcast of the presentation can be accessed at www...
Other Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: